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An Outbreak of Spotted Fever Rickettsiosis
in U.S. Army Troops Deployed to Botswana
Novel infectious diseases are recognized when
nonimmune persons move into the ecologic niche
of a pathogen and become inadvertent hosts. One
population at  frequent risk to such emerging patho-
gens is the military. Historical examples of this
phenomenon include outbreaks of scrub typhus dur-
ing World War II and Korean hemorrhagic fever
during the Korean War (1).  In this report, we de-
scribe a modern example as we document an
unusually high attack rate of a rickettsial disease
among U.S. troops camping for a brief period in Af-
rica.
In January 1992, U.S. soldiers participated in a
10-day training exercise with the Botswana Defense
Force near Shoshong, Botswana. Activities included
individual weapons’ training and a series of mock
battles.  The terrain was generally flat with scat-
tered bushes and small trees. The climate was
semiarid, and temperatures reached 120°F during
the day.  During the fieldexercise, one soldier sought
medical assistance to remove small “insects” crawl-
ing rapidly on his body.  No specimens were reliably
identified in the field or preserved for subsequent
examination.  No unusual illnesses  were reported
to medical personnel during the training exercise.
After the field-training exercises, the soldiers spent
2 days in Gaborone, the capital of Botswana. Within
2 days of their return to their home station, approxi-
mately 30% of the deployed soldiers sought medical
attention with symptoms of  fever, headache, and
regional lymphadenitis. Several soldiers reported
insect bites. An epidemiologic team from Walter
Reed Army Institute of Research was sent to
Botswana to assist with the outbreak investigation.
From airplane manifests, 169 soldiers were iden-
tified as having been deployed to Botswana.  One
week after the soldiers returned to their home sta-
tion, a questionnaire requesting information on
symptoms, personal protective measures taken
against arthropod vectors, reservoir exposures, and
other potential risk factors for infection was admin-
istered to all available soldiers (n = 140); 132 soldiers
underwent directed physical examinations, in which
skin lesions, lymphadenopathy, and right upper
quadrant tenderness were noted. Clothing and
equipment used in the field that had not been
cleaned since the exercise were visually examined
in detail by a  team of entomologists. Blood samples
from 126 soldiers were obtained at 1 week and 10
weeks postdeployment.  Serum specimens were di-
vided into aliquots and frozen at -20°C for labora-
tory analyses.
Sera were tested for antibodies to rickettsiae by
using an indirect fluorescence antibody technique
 (IFA) (2).  Sera drawn at 10 weeks postdeployment
were initially screened for whole immunoglobulin
reactivity against  Rickettsia conorii Moroccan
strain, a member of the spotted fever group of rick-
ettsiae that cause boutonneuse fever. Subsequently,
sera showing titers >1:64 were paired with their re-
spective 1-week samples and titered to the endpoint,
defined as the highest dilution showing discernible
fluorescing organisms. The rickettsial species used
as antigens for antibody titration included cell
culture–propagated R. conorii (Moroccan, ATCC VR-
141), Rickettsia akari Hartford, and Rickettsia typhi
(Wilmington,  ATCC VR-144).  The latter two mi-
croorganisms are the etiologic agents of rickettsial
pox and murine typhus, respectively. Slides were
read by one technician who was blinded to the clini-
cal history corresponding to the sample.
A case-patient was defined as a soldier who had
either a fourfold or greater rise in immunoglobulin
G (IgG) titer to R. conorii within 9 weeks to a titer
>1:128 by IFA, or clinically, by the presence of a tache
noire (eschar) and at least two of the following symp-
toms: regional lymphadenitis, fever, chills, severe
headache, and muscle or joint pains. By this case
definition, the overall attack rate was 23% (39 of
169 soldiers).  Of  36 case-patients who provided
paired serum samples, 24 (67%) seroconverted dur-
ing the postdeployment period.  All 24 case-patients
who seroconverted were symptomatic, but six did
not have an eschar.  Of the 15 case-patients without
documented fourfold rises in titer, all had at least
one eschar and regional lymphadenitis observed by
a physician. Three of the soldiers who did not
seroconvert, but were identified as case-patients by
the clinical definition, had high standing titers,
>1:256.
One week after returning from Botswana, the
case-patients (n = 36) had a geometric mean
 reciprocal (GMT) IgG titer to R. conorii of 43, which
increased to 185 9 weeks later (Student’s t test
paired,  p < 0.0001).  Over the same period, the GMT
of non-case-patients (n = 38) who had positive titers
on the initial whole immunoglobulin screening re-
mained the same at 38. To determine whether early
treatment impaired antibody production, the case-
patients were divided into two groups: those whoEmerging Infectious Diseases Vol. 2, No. 3—July-September 1996
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received treatment within 2 days of the start of their
symptoms (n = 12) and those who received treat-
ment 3 or more days later (n = 21).  The group that
was treated early had a lower mean GMT at follow-
up, but the difference was not statistically significant
(early 136, 95% confidence interval [C.I.]: 77, 239:
late 197, 95% C.I.: 114, 338).
A Western blot immunoassay was used (3).  Rick-
ettsial antigens (R. typhi Wilmington, R. akari,
Rickettsia africae F (4,5), R. conorii Malish (ATCC
VR613), and Israeli tick typhus rickettsiae (T-487))
used in the immunoblots, either boiled or solubilized
at room temperature, were electrophoresed on an
8% to 16% gradient PAGE gel. Renografin density
gradient purified antigen was applied at 20 mg
protein per lane.  R. typhi was yolk sac–propagated,
whereas spotted fever group antigens were grown
in irradiated L cells.  Patients’ serum specimens
were reacted with the electrophoresed antigens at
1:250 dilution. Horseradish peroxidase–labeled goat
antibodies against human IgG (gamma-chain-spe-
cific) and IgM ( m chain-specific) (Calbiochem, San
Diego, CA) were used at 1:1000 dilution, and bound
antibody was detected with 4-Cl-1-naphthol-H2O2 re-
agent.  Prestained SDS-PAGE molecular weight
standards (Bio-Rad, Melville, NY) were used to es-
timate antigen sizes
Western blots were used to char-
acterize the serologic reactivities of
38 case-patients and 37 non–case-
patients. Serum specimens were
considered positive for reactivity
with spotted fever rickettsial anti-
gens  if a characteristic broad
washboard of  spotted fever group li-
popolysaccharide reactivity (SFG
LPS) was observed in the 20- to 40-
kDa region with anti-IgG conjugate
(Figure 1). Most of these serum
specimens also exhibited pro-
nounced IgM reactivity, which
sometimes included R. typhi LPS.
Serologic specificity toward the in-
dividual spotted fever species was
determined by the relative IgG re-
activity to species-specific antigens
(SPAs) solubilized at room tempera-
ture found at 125 to 145 kDa.
Thirty-two of the 38 case-patient
specimens tested by Western blot
were positive for spotted fever group
IgG LPS.
On Western blot, the sera of 23
case-patients reacted most strongly
with R. africae SPA (not shown), one with R. conorii
SPA, and eight showed no specificity (Figure 1). Nine
of 37 soldiers who did not meet our case definition
were positive for spotted fever group IgG LPS.  The
specimens of two reacted primarily with R. africae
SPA, and specimens from the remaining seven had
nonspecific patterns. Five of these nine soldiers re-
ported no symptoms.  Two soldiers reported a runny
nose, another reported a rash on the dorsal portion
of the right upper arm, and another had a tender
raised papule. By Western blot criteria, these nine
soldiers would be considered infected and may rep-
resent asymptomatic cases. However, they did not
meet our case definition and were not counted as
case-patients in our analyses.
Patients' sera showed expected broad cross-re-
activity with other spotted fever group rickettsiae
by IFA. In sera collected at 10 weeks, 17 (51%) of
the case-patients had identical R. akari and R.
conorii titers; a difference of one dilution in titers
was observed in12 (36%) of the case-patients. The
remaining cases had R. akari titers that were four-
fold less than their R. conorii titer.  However,  no
Western blots were positive for R. akari. All  but
two 10-week serum samples from the case-patients
were nonreactive at a titer of <1:32 with R. typhi
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Figure 1. Western blot reactivity of convalescent-phase serum from a
patient with spotted fever rickettsiosis with high standing titers.  An-
tigens from the rickettsial isolates were solubilized at room temperature
or boiled for 5 minutes before electrophoresis. The darkest large bands
indicate R. africae, R. conorii, and Israeli tick typhus rickettsiae [ISTT]
(no specificity detected). R. typhi is a member of the typhus group of
rickettsiae, whereas all other isolates are members of the spotted fever
group.Vol. 2, No. 3—July-September 1996 Emerging Infectious Diseases
Dispatches
219
antigen by IFA, and none were positive by Western
blot. Serum from one case-patient had titers of 1:128
o R. akari, R. typhi, and R. conorii. Serum from the
second case-patient had titers of 1:512 to R. conorii
and 1:64 to R. typhi.
Median ages of the case-patients and non–case-
patients were 23.5 and 22 years, respectively.
Although a larger proportion of cases was found
among the older age groups, this trend was not sig-
nificant (c 2 trend, p = 0.28). Most of the soldiers
(77%) were non-Hispanic white. There were too few
soldiers in other race-ethnic groups to make sepa-
rate comparisons, but when those from other ethnic
backgrounds were combined into one group, the
group had an attack rate (22%) similar to that of
the non-Hispanic white soldiers (24%).
The illness observed in the soldiers was mild to
moderately severe. Although all cases were symp-
tomatic, some came to medical attention only
through active case finding.  Many case-patients had
systemic complaints, commonly described as
“flulike.”  Each of the classic symptoms associated
with rickettsial diseases (i.e., fever, chills, headache,
myalgia, and arthralgia) was reported by at least
59% of the case-patients but by fewer than 10% of
the non–case-patients (Table 1). Gastrointestinal
complaints of stomach pain, anorexia, nausea, or
vomiting were also reported more frequently by the
case-patients than by the non–case-patients. In con-
trast, diarrhea and upper respiratory symptoms
were reported at similar rates among case-patients
and non–case-patients. On physical examination,
lymphadenitis was observed in 36 (92%) and right
upper quadrant tenderness in 17 (44%) of the case-
patients. The skin lesions began as a tender
erythematous papule, which progressed over 24 to
36 hours to form one to three clear vesicles. The frag-
ile vesicles ruptured, exposing an erythematous
base, which darkened into a small eschar. The total
duration of the evolution was 72 to 96 hours; 34
(87%) of case-patients had at least one eschar, and
10 of the case-patients had more than one. Of all
eschars reported during physical examinations, 50%
were located on the trunk; others were located on
the head, neck, extremities, penis, and scrotum. No
soldiers were hospitalized, and all case-patients re-
sponded rapidly to antibiotic treatment.
An incubation period of up to 6 days was esti-
mated from the histories of the first two
case-patients (Figure 2).  The first case-patient re-
ported onset of symptoms on January 20, 6 days
after he arrived in Botswana as a member of an
advance team.  The second case-patient arrived in
Botswana on January 18 and had onset of symp-
toms 6 days later.  Thus, assuming a Botswana
exposure, the time from infection to symptoms in
these two case-patients could not have exceeded 6
days, an incubation time consistent with the 5- to
7-day period commonly reported for African spotted
fever rickettsioses.  Finally, since most case-patients
reported symptoms during the 3 days before or the
4 days after leaving Botswana, we concluded that
the period of high risk exposures occurred during
field training in Shoshong and not in Gaborone.
Screening of clothing used during the field train-
ing found a crushed trombiculid mite on the boot of
one of the case-patients. In addition, a live
Hyalomma marginatum tick was found on para-
chute rigging used in Botswana. No rickettsiae were
isolated from the tick or any human specimens.
No significant differences were found between
case-patients and others in reported exposure to vec-
tors, such as mosquitoes (68% vs. 62%; c 2,  p = 0.53)
and chiggers (19% vs 10%; c 2, p = 0.14).  However,
case-patients (68%) were more likely
than non–case-patients (40%) to re-
port tick bites (c 2, p = 0.007). Only
one soldier reported finding an en-
gorged tick on his body.  Fewer than
50% of all deployed soldiers reported
using a DEET-containing insect re-
pellent at any time during the
exercise, and fewer than 10% of the
soldiers reported using permethrin
(anacaricide and repellent applied to
clothing). No statistical differences
were found between case-patients
and non–case patients in reported
uses of these personal protective mea-
sures. Self-reported exposures of
case-patients (n = 31) vs non-case-pa-
tients (n = 101) to potential reservoirs
Table 1. Symptoms of case-patients and non–case-patients during a spotted fever
outbreak
Case–patients; Non–case-patients; Risk 95% Confidence
Symptoms n=32(%) n=107(%) ratio interval
Fever 19 (59)   8 (7)   6.06 3.44,10.68
Chills 25 (78)   6 (6) 12.44 5.96,26.00
Headache 23 (72)   8 (7)   8.90 4.61,17.21
Muscle ache 26 (81) 10 (9) 12.40 5.56,27.66
Joint pain 21 (66)   9 (8)   6.94 3.78,12.73
Fatigue 27 (84)   6 (6) 17.35 7.26,41.43
Lymphadenitis 27 (84)   3 (3) 19.62 8.27,46.57
Abdominal pain   9 (28)   4 (4)   3.79 2.26,6.36
Anorexia  11 (34)   3 (3)   4.68 2.90,7.53
Nausea/vomiting  13 (41)   3 (3)   5.26 3.27,8.46
Diarrhea   7 (22)  21 (20)   1.11 0.54,2.30
Cough   4 (12)   9 (8)   1.38 0.58,3.33
Nasal congestion   7 (22) 17 (16)   1.34 0.66,2.74
Sore throat   6 (19) 16 (15)   1.23 0.57,2.63Emerging Infectious Diseases Vol. 2, No. 3—July-September 1996
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of  R. conorii (dogs: 52% vs 56%; rodents: 10% vs
35%; antelopes: 3% vs 7%; cattle: 81% vs 87%;
horses:16% vs 25%; sheep: 42% vs 38%; and goats:
90% vs 87%) were not statistically different.
More than 85% (n = 117) of the soldiers slept on
sleeping pads placed directly on the ground. Few (n
= 18) soldiers reported sleeping on cots, litters, ham-
mocks, or pallets. The attack rate was approximately
twice as high among men sleeping on the ground
(25%) as among those who did not (11%). Because of
the small number who slept off the ground, this dif-
ference, was not statistically significant (risk ratio
= 2.23; 95% C.I.: 0.58, 8.56).  The attack rate among
soldiers who maneuvered in the field during daily
training exercises was lower than the rate among
soldiers who remained at base camp (24% vs. 33%,
respectively), but the difference was also not statis-
tically significant (odds ratio = 1.40, 95% C.I.: 0.77,
2.56).
This report documents the occurrence of a large
focal outbreak of a spotted fever group rickettsiosis
among American soldiers participating in a  short
field-training exercise in Botswana. Little is known
about the epidemiology of rickettsial diseases in
Botswana. However, during the civil unrest that oc-
curred in neighboring Rhodesia (now Zimbabwe) in
the late 1970s, several thousand cases of tick ty-
phus were reported among military personnel.  In
Zimbabwe, ticks removed from 100 soldiers were all
larvae of Amblyomma hebraeum (6). In another
study, 33% to 75% of A. hebraeum ticks, collected
from animals or vegetation in four regions of Zim-
babwe, were heavily infested with rickettsialike
organisms (7). Only the re-
cently characterized new
rickettsia R. africae, but not R.
conorii, the etiologic agent of
boutonneuse fever, was de-
tected in these ticks (4,7). In
contrast, the dog ticks
Rhipicephalus simus and
Haemaphysalis leachi were
less heavily infected (0% to
21%) and were only infected
with R. conorii.  R. africae has
also been isolated from a hos-
pitalized patient with fever,
severe headache, and regional
lymph-adenopathy but no rash
other than an erythematous
tick bite site(8).
On the other hand, in his
original 1934 clinical descrip-
tion of   African tick bite fever,
Pijper (9) described a patient
with a rash and eschar, whose condition he care-
fully distinguished from bouton-neuse fever. He
clearly associated this milder disease with the
“hardly visible” swarming larval veld ticks (“little
pests”) and not dog ticks. He also noted that even if
the disease was not severe, it needed to be  recog-
nized by physicians and not confused with other
potentially more devastating illnesses requiring
more aggressive therapy.
Recent surveys of human antibodies in eight Af-
rican countries have suggested a seroprevalence of
antibodies to spotted fever rickettsiae of 0% to 52%,
which parallels the distribution of  Amblyomma ticks
(10,11).  The etiologic agent appeared to be R. africae,
based on Western blot analysis (10).  IFA analysis
has been found inadequate in distinguishing human
infections with R. africae and R. conorii (11).
The collective observations parallel our clinical,
epidemiologic, and serologic findings on the
Botswana outbreak and are most consistent with
disease caused by R. africae. R. africae is closely
related to R. conorii but has been proposed as a new
species (5). Whether we consider this a newly emerg-
ing rickettsiosis or, in deference to the pioneering
work of Pijper, a disease reemerging into our con-
sciousness, African tick bite fever caused by R.
africae may be epidemiologically distinct from ur-
ban R. conorii infections.
We have established the potential for high at-
tack rates of this spotted fever rickettsiosis, but
much more needs to be understood about the clini-
cal severity of this disease and its potential for
asymptomatic infections. Physically fit, healthy,
Figure 2.  Epidemic curve of a spotted fever outbreak among U.S. troops.Vol. 2, No. 3—July-September 1996 Emerging Infectious Diseases
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young soldiers may not represent a particularly
good model for assessing the severity of disease in
populations residing in areas where the disease is
endemic.
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